Brodalumab in plaque psoriasis: Real-world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks.

Natalia RompotiMaria PolitouIrene StefanakiCharitomeni VavouliMarina PapoutsakiAfroditi NeofotistouDimitrios RigopoulosAlexander StratigosElectra Nicolaidou
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Our study confirms the high effectiveness and good safety profile of brodalumab in the real-world setting.